Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Bornova
Clinical trial register · Turkey

Clinical Trials in Bornova, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Turkey and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5418 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5418
Studies in scope
all four open statuses
2461
Recruiting now
open to new participants
548
Lead sponsors
across recruiting studies
Top sites
Ankara 26 Adana 21 Antalya 20 Istanbul 20 Edirne 17
Narrow the registerReset
Recruitment status
Phase
Site location
Ankara26 Adana21 Antalya20 Istanbul20 Edirne17
All 39 locations
Target enrolment
to

Trials with a site in Bornova

9 of 5418 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Turkey
Start
Recruiting
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
NCT07415044Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate, Ulcerative Colitis, Active Severe
Eli Lilly and Company
Phase 2
1,431
Adana, Ankara, Antalya, Bornova, Hatay, Istanbul, İzmit, Mersin
2026-03-26
Recruiting
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
NCT07169851Nausea, Vomiting, Drug-Related Side Effects and Adverse Reactions, Neoplasms
Eli Lilly and Company
Phase 2
204
Adana, Ankara, Antalya, Bornova, Edirne, Gaziantep, Pendik, Sakarya
2025-11-28
Active, closed
Eli Lilly and Company
Phase 3
10,000
Afyonkarahisar, Ankara, Antalya, Bornova, Çorum, Edirne, Eskişehir, Gaziantep
2024-04-30
Active, closed
Eli Lilly and Company
Phase 3
15,374
Adana, Ankara, Antalya, Aydin, Balçova, Bornova, Denizli, Gaziantep
2022-10-11
Active, closed
Eli Lilly and Company
Phase 3
152
Bornova, Izmir, Karsiyaka, Adana, Ankara, Antalya, Bursa, Diyarbakır, Edirne
2021-12-20
Active, closed
Eli Lilly and Company
Phase 3
261
Bornova, Adana, Ankara, Antalya, Diyarbakır, Edirne, Istanbul, Izmir
2020-02-17
Active, closed
Eli Lilly and Company
Phase 3
1,058
Antalya, Bornova, Kocaeli, Mersin
2018-07-18
Active, closed
Eli Lilly and Company
Phase 3
5,637
Istanbul- Fatih, Üsküdar/stanbul, Bornova, Izmir, Karsiyaka, Ankara, Adana, Antalya, Edirne
2017-07-12
Active, closed
Eli Lilly and Company
Phase 3
545
Bornova, Adana, Edirne, Malatya
2015-05-06
Rows per page Showing 1–9 of 9
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Turkish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-turkey/city/bornova

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Turkey and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,418 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 9 of those studies with a site in Bornova that also match the filters currently applied.

How many clinical trials are recruiting in Bornova?

2 of the 9 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 7 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Bornova), 9 studies
PhaseStudiesRecruitingShare
Phase 37077.8%
Phase 22222.2%

Most active sponsors

Lead sponsors with the most studies (Bornova)
Lead sponsorStudiesRecruiting
Eli Lilly and Company92
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.